These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 27390335)

  • 1. Noninvasive Molecular Imaging of Disease Activity in Atherosclerosis.
    Dweck MR; Aikawa E; Newby DE; Tarkin JM; Rudd JH; Narula J; Fayad ZA
    Circ Res; 2016 Jul; 119(2):330-40. PubMed ID: 27390335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-FDG imaging of atherosclerosis: will imaging of MMPs assess plaque vulnerability?
    Hermann S; Starsichova A; Waschkau B; Kuhlmann M; Wenning C; Schober O; Schäfers M
    J Nucl Cardiol; 2012 Jun; 19(3):609-17. PubMed ID: 22477642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular imaging of atherosclerosis with integrated PET imaging.
    Hammad B; Evans NR; Rudd JHF; Tawakol A
    J Nucl Cardiol; 2017 Jun; 24(3):938-943. PubMed ID: 28078575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Osteogenesis and Inflammation During the Progression of Calcified Plaque Evaluated by
    Li X; Heber D; Cal-Gonzalez J; Karanikas G; Mayerhoefer ME; Rasul S; Beitzke D; Zhang X; Agis H; Mitterhauser M; Wadsak W; Beyer T; Loewe C; Hacker M
    J Nucl Med; 2017 Jun; 58(6):968-974. PubMed ID: 28232606
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeting P-selectin by gallium-68-labeled fucoidan positron emission tomography for noninvasive characterization of vulnerable plaques: correlation with in vivo 17.6T MRI.
    Li X; Bauer W; Israel I; Kreissl MC; Weirather J; Richter D; Bauer E; Herold V; Jakob P; Buck A; Frantz S; Samnick S
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1661-7. PubMed ID: 24903095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-Modality Activity-Based Probes as Molecular Imaging Agents for Vascular Inflammation.
    Withana NP; Saito T; Ma X; Garland M; Liu C; Kosuge H; Amsallem M; Verdoes M; Ofori LO; Fischbein M; Arakawa M; Cheng Z; McConnell MV; Bogyo M
    J Nucl Med; 2016 Oct; 57(10):1583-1590. PubMed ID: 27199363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic and Molecular Imaging of Atherosclerosis and Venous Thromboembolism.
    Osborn EA; Kessinger CW; Tawakol A; Jaffer FA
    J Nucl Med; 2017 Jun; 58(6):871-877. PubMed ID: 28450558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of α7 nicotinic acetylcholine receptor PET imaging in atherosclerosis.
    Boswijk E; Bauwens M; Mottaghy FM; Wildberger JE; Bucerius J
    Methods; 2017 Nov; 130():90-104. PubMed ID: 28602809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should vascular wall
    Lensen KDF; Voskuyl AE; Comans EFI; van der Laken CJ; Boellaard R; Smulders YM
    Int J Cardiovasc Imaging; 2020 Mar; 36(3):545-551. PubMed ID: 31898005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Imaging of Atherothrombotic Diseases: Seeing Is Believing.
    Wang X; Peter K
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1029-1040. PubMed ID: 28450298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the nature of atheroma and cardiovascular inflammation in vivo using positron emission tomography (PET).
    Buscombe JR
    Br J Radiol; 2015 Sep; 88(1053):20140648. PubMed ID: 26110339
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Kitagawa T; Yamamoto H; Toshimitsu S; Sasaki K; Senoo A; Kubo Y; Tatsugami F; Awai K; Hirokawa Y; Kihara Y
    Atherosclerosis; 2017 Aug; 263():385-392. PubMed ID: 28528743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel non-invasive approach for visualizing inflamed atherosclerotic plaques using fluorodeoxyglucose-positron emission tomography.
    Kai H
    Geriatr Gerontol Int; 2010 Jan; 10(1):1-8. PubMed ID: 20102376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear Imaging: Focus on Vascular Probes.
    Hyafil F; Vigne J
    Arterioscler Thromb Vasc Biol; 2019 Jul; 39(7):1369-1378. PubMed ID: 31242032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular imaging of plaque vulnerability.
    Tavakoli S; Vashist A; Sadeghi MM
    J Nucl Cardiol; 2014 Dec; 21(6):1112-28; quiz 1129. PubMed ID: 25124827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innovation in medical imaging to improve disease staging, therapeutic intervention, and clinical outcomes.
    Daghem M; Newby DE
    Atherosclerosis; 2020 Aug; 306():75-84. PubMed ID: 32331772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary Artery PET/MR Imaging: Feasibility, Limitations, and Solutions.
    Robson PM; Dweck MR; Trivieri MG; Abgral R; Karakatsanis NA; Contreras J; Gidwani U; Narula JP; Fuster V; Kovacic JC; Fayad ZA
    JACC Cardiovasc Imaging; 2017 Oct; 10(10 Pt A):1103-1112. PubMed ID: 28109921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET and SPECT imaging of apoptosis in vulnerable atherosclerotic plaques with radiolabeled Annexin A5.
    Laufer EM; Winkens HM; Corsten MF; Reutelingsperger CP; Narula J; Hofstra L
    Q J Nucl Med Mol Imaging; 2009 Feb; 53(1):26-34. PubMed ID: 19182725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular imaging of atherosclerotic lesions by positron emission tomography - can it meet the expectations?
    Brammen L; Steiner S; Berent R; Sinzinger H
    Vasa; 2016; 45(2):125-32. PubMed ID: 27058798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Imaging of Vulnerable Atherosclerotic Plaques in Animal Models.
    Gargiulo S; Gramanzini M; Mancini M
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27618031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.